Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mahony

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Orthopaedic and Sports Physical Therapy|July 14, 2001
Comparison of acute swelling and function in subjects with lateral ankle injuryM L Pugia, C J Middel, S W Seward, et al.
The American Journal of Drug and Alcohol Abuse|February 9, 2018
Open-label pilot study of injectable naltrexone for cannabis dependenceDaniel P Notzon, Meredith A Kelly, C Jean Choi, et al.
Drug and Alcohol Dependence|January 8, 2021
Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trialFrances R Levin, John J Mariani, Martina Pavlicova, et al.
The American Journal on Addictions|July 5, 2021
Open-label trial of a single-day induction onto buprenorphine extended-release injection for users of heroin and fentanylJohn J Mariani, Amy L Mahony, Samuel C Podell, et al.
The American Journal of Drug and Alcohol Abuse|October 4, 2023
Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorderJohn J Mariani, Cale Basaraba, Martina Pavlicova, et al.
Journal of Attention Disorders|July 25, 2024
Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled TrialFrances R Levin, John J Mariani, Martina Pavlicova, et al.
Journal of Substance Use|July 18, 2024
Open Label Pilot of Lorcaserin (a serotonin 2C-receptor agonist) for Cannabis Use DisorderChristina A Brezing, Mohammad Sibai, C Jean Choi, et al.
The American Journal of Drug and Alcohol Abuse|June 7, 2021
An open-label pilot study of pregabalin pharmacotherapy for alcohol use disorderJohn J Mariani, Martina Pavlicova, C Jean Choi, et al.
Drug and Alcohol Dependence|November 6, 2020
Quetiapine treatment for cannabis use disorderJohn J Mariani, Martina Pavlicova, C Jean Choi, et al.
Pediatric Cardiology|November 2, 2005
The Pediatric Heart Network: a primer for the conduct of multicenter studies in children with congenital and acquired heart diseaseL Mahony, L A Sleeper, P A W Anderson, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Orthopaedic and Sports Physical Therapy|July 14, 2001
Comparison of acute swelling and function in subjects with lateral ankle injuryM L Pugia, C J Middel, S W Seward, et al.
The American Journal of Drug and Alcohol Abuse|February 9, 2018
Open-label pilot study of injectable naltrexone for cannabis dependenceDaniel P Notzon, Meredith A Kelly, C Jean Choi, et al.
Drug and Alcohol Dependence|January 8, 2021
Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trialFrances R Levin, John J Mariani, Martina Pavlicova, et al.
The American Journal on Addictions|July 5, 2021
Open-label trial of a single-day induction onto buprenorphine extended-release injection for users of heroin and fentanylJohn J Mariani, Amy L Mahony, Samuel C Podell, et al.
The American Journal of Drug and Alcohol Abuse|October 4, 2023
Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorderJohn J Mariani, Cale Basaraba, Martina Pavlicova, et al.
Journal of Attention Disorders|July 25, 2024
Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled TrialFrances R Levin, John J Mariani, Martina Pavlicova, et al.
Journal of Substance Use|July 18, 2024
Open Label Pilot of Lorcaserin (a serotonin 2C-receptor agonist) for Cannabis Use DisorderChristina A Brezing, Mohammad Sibai, C Jean Choi, et al.
The American Journal of Drug and Alcohol Abuse|June 7, 2021
An open-label pilot study of pregabalin pharmacotherapy for alcohol use disorderJohn J Mariani, Martina Pavlicova, C Jean Choi, et al.
Drug and Alcohol Dependence|November 6, 2020
Quetiapine treatment for cannabis use disorderJohn J Mariani, Martina Pavlicova, C Jean Choi, et al.
Pediatric Cardiology|November 2, 2005
The Pediatric Heart Network: a primer for the conduct of multicenter studies in children with congenital and acquired heart diseaseL Mahony, L A Sleeper, P A W Anderson, et al.
Pageof 6